Mercado europeo del cáncer colorrectal hasta 2027: análisis regional y pronósticos por modalidad (tipo de diagnóstico, tipo de terapia, tipo de imágenes); Usuario final (hospitales, laboratorios de diagnóstico e investigación) y país
Se espera que el mercado del cáncer colorrectal en Europa crezca de 4.627,82 millones de dólares en 2022 a 5.819,96 millones de dólares en 2028; se estima que crecerá a una tasa compuesta anual del 2,9% de 2022 a 2028.
Se atribuye el mercado del cáncer colorrectal a frecuentes pruebas de diagnóstico y lanzamientos de nuevos fármacos. Muchos actores importantes del mercado participan en la fabricación de una amplia gama de medicamentos y pruebas de diagnóstico que ayudan a reducir la carga del cáncer colorrectal. Por ejemplo, en junio de 2021, Bristol Myers Squibb anunció la aprobación de Opdivo más Yervoy por parte de la Comisión Europea (CE) para el tratamiento de pacientes adultos con cáncer colorrectal metastásico con inestabilidad de microsatélites alta (MSI-H). Además, en septiembre de 2019, Lupin, una empresa farmacéutica india, se asoció con Boehringer Ingelheim, una empresa farmacéutica con sede en Alemania, para el desarrollo de medicamentos contra el cáncer. Las empresas colaboraron para desarrollar y comercializar un fármaco basado en el inhibidor MEK. Es probable que la molécula se dirija a células cancerosas específicas y trate a pacientes que padecen cáncer de estómago y de piel. En junio de 2019, Pfizer, Inc. lanzó ZIRABEV, un biosimilar de Avastin que ayuda en el tratamiento de cinco cánceres, incluido el cáncer colorrectal. Por lo tanto, los constantes desarrollos y lanzamientos de nuevos productos en el diagnóstico y la terapia del cáncer colorrectal están impulsando el crecimiento del mercado del cáncer colorrectal en Europa.
Con la Con nuevas características y tecnologías, los proveedores pueden atraer nuevos clientes y ampliar su presencia en los mercados emergentes. Es probable que este factor impulse el mercado europeo del cáncer colorrectal a una tasa compuesta anual sustancial durante el período de pronóstico.
Europa colorrectal Cáncer
Ingresos del mercado y pronóstico hasta 2028 (millones de dólares estadounidenses)
< /strong>
Segmentación del mercado del cáncer colorrectal en Europa
El mercado europeo del cáncer colorrectal está segmentado por modalidad, usuario final y país. Según la modalidad, el mercado europeo del cáncer colorrectal se segmenta en tipo de diagnóstico, tipo de terapia y tipo de imagen. En 2022, el segmento de tipo de diagnóstico tuvo la mayor participación de mercado y se espera que registre la CAGR más alta durante el período de pronóstico. Según el usuario final, el mercado europeo del cáncer colorrectal se divide en hospitales y centros de diagnóstico y diagnóstico. laboratorios de investigación. En 2022, el segmento de hospitales tenía una mayor cuota de mercado. Según el país, el mercado europeo del cáncer colorrectal está segmentado en Francia, Alemania, Italia, España, el Reino Unido y el resto de Europa. El resto de Europa tuvo la mayor cuota de mercado en 2022.
Abbott, Amgen Inc., Bruker Corporation, EDP Biotech Corporation, Epigenomics AG , F. Hoffmann-La Roche AG, Quest Diagnostics y VolitionRx Limited se encuentran entre las empresas líderes que operan en el mercado europeo del cáncer colorrectal.
Europe Colorectal Cancer Strategic Insights
Strategic insights for Europe Colorectal Cancer involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
Get more information on this report
Europe Colorectal Cancer Report Scope
Report Attribute
Details
Market size in 2022
US$ 4,627.82 Million
Market Size by 2028
US$ 5,819.96 Million
Global CAGR (2022 - 2028)
2.9%
Historical Data
2020-2021
Forecast period
2023-2028
Segments Covered
By Modalidad
Tipo de diagnóstico
Tipo de terapia
Tipo de imagen
By Usuario final
hospitales
laboratorios de diagnóstico e investigación
Regions and Countries Covered
Europa
Reino Unido
Alemania
Francia
Rusia
Italia
resto de Europa
Market leaders and key company profiles
Abbott
Amgen Inc.
Bruker Corporation
Clinical Genomics Technologies Pty Ltd.
Epigenomics AG
F. Hoffmann-La Roche AG
Quest Diagnostics
VolitionRx Limited
Get more information on this report
Europe Colorectal Cancer Regional Insights
The regional scope of Europe Colorectal Cancer refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
Get more information on this report
Identical Market Reports with other Region/Countries
The List of Companies - Europe Colorectal Cancer Market
Abbott
Amgen Inc.
Bruker Corporation
Clinical Genomics Technologies Pty Ltd.
Epigenomics AG
F. Hoffmann-La Roche AG
Quest Diagnostics
VolitionRx Limited
Frequently Asked Questions
How big is the Europe Colorectal Cancer Market?
The Europe Colorectal Cancer Market is valued at US$ 4,627.82 Million in 2022, it is projected to reach US$ 5,819.96 Million by 2028.
What is the CAGR for Europe Colorectal Cancer Market by (2022 - 2028)?
As per our report Europe Colorectal Cancer Market, the market size is valued at US$ 4,627.82 Million in 2022, projecting it to reach US$ 5,819.96 Million by 2028. This translates to a CAGR of approximately 2.9% during the forecast period.
What segments are covered in this report?
The Europe Colorectal Cancer Market report typically cover these key segments-
Modalidad (Tipo de diagnóstico, Tipo de terapia, Tipo de imagen)
Usuario final (hospitales, laboratorios de diagnóstico e investigación)
What is the historic period, base year, and forecast period taken for Europe Colorectal Cancer Market?
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Colorectal Cancer Market report:
Historic Period : 2020-2021
Base Year : 2022
Forecast Period : 2023-2028
Who are the major players in Europe Colorectal Cancer Market?
The Europe Colorectal Cancer Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
Abbott
Amgen Inc.
Bruker Corporation
Clinical Genomics Technologies Pty Ltd.
Epigenomics AG
F. Hoffmann-La Roche AG
Quest Diagnostics
VolitionRx Limited
Who should buy this report?
The Europe Colorectal Cancer Market report is valuable for diverse stakeholders, including:
Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.
Essentially, anyone involved in or considering involvement in the Europe Colorectal Cancer Market value chain can benefit from the information contained in a comprehensive market report.
Get Free Sample For Europe Colorectal Cancer Market
1. Complete the form
2. Check your inbox (and spam/junk folder)
3. Your Personal Data is Secure with us
GDPR + CCPA Compliant
Personal & transactional information is kept safe from unauthorized use.
WHAT'S INCLUDED IN FULL REPORT : Market Dynamics,
Competitive Analysis and Assessment, Define Business Strategies, Market Outlook and
Trends, Market Size and Share Analysis, Growth Driving Factors, Future Commercial
Potential, Identify Regional Growth Engines